BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32539073)

  • 1. Layilin augments integrin activation to promote antitumor immunity.
    Mahuron KM; Moreau JM; Glasgow JE; Boda DP; Pauli ML; Gouirand V; Panjabi L; Grewal R; Luber JM; Mathur AN; Feldman RM; Shifrut E; Mehta P; Lowe MM; Alvarado MD; Marson A; Singer M; Wells J; Jupp R; Daud AI; Rosenblum MD
    J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32539073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8
    Yang B; Deng B; Jiao XD; Qin BD; Lu Y; Zhang W; Guo Y; Chen S; Li D; Li B; Zang YS
    Cell Oncol (Dordr); 2022 Dec; 45(6):1297-1309. PubMed ID: 36260222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emerging Role of CD8
    Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
    Front Immunol; 2018; 9():1904. PubMed ID: 30158938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Layilin, a novel talin-binding transmembrane protein homologous with C-type lectins, is localized in membrane ruffles.
    Borowsky ML; Hynes RO
    J Cell Biol; 1998 Oct; 143(2):429-42. PubMed ID: 9786953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Layilin Anchors Regulatory T Cells in Skin.
    Mehta P; Gouirand V; Boda DP; Zhang J; Gearty SV; Zirak B; Lowe MM; Clancy S; Boothby I; Mahuron KM; Fries A; Krummel MF; Mankoo P; Chang HW; Liu J; Moreau JM; Scharschmidt TC; Daud A; Kim E; Neuhaus IM; Harris HW; Liao W; Rosenblum MD
    J Immunol; 2021 Oct; 207(7):1763-1775. PubMed ID: 34470859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
    Demaria O; De Gassart A; Coso S; Gestermann N; Di Domizio J; Flatz L; Gaide O; Michielin O; Hwu P; Petrova TV; Martinon F; Modlin RL; Speiser DE; Gilliet M
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15408-13. PubMed ID: 26607445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response.
    Reiser J; Banerjee A
    J Immunol Res; 2016; 2016():8941260. PubMed ID: 27314056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the interaction between the cytoplasmic domain of the hyaluronate receptor layilin and the talin F3 subdomain.
    Wegener KL; Basran J; Bagshaw CR; Campbell ID; Roberts GC; Critchley DR; Barsukov IL
    J Mol Biol; 2008 Sep; 382(1):112-26. PubMed ID: 18638481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patients.
    Chauvin JM; Pagliano O; Fourcade J; Sun Z; Wang H; Sander C; Kirkwood JM; Chen TH; Maurer M; Korman AJ; Zarour HM
    J Clin Invest; 2015 May; 125(5):2046-58. PubMed ID: 25866972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens.
    Morgan RA; Dudley ME; Yu YY; Zheng Z; Robbins PF; Theoret MR; Wunderlich JR; Hughes MS; Restifo NP; Rosenberg SA
    J Immunol; 2003 Sep; 171(6):3287-95. PubMed ID: 12960359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 13. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
    Yin W; Song Y; Liu Q; Wu Y; He R
    Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of layilin in TNF-α-induced epithelial-mesenchymal transformation of renal tubular epithelial cells.
    Adachi T; Arito M; Suematsu N; Kamijo-Ikemori A; Omoteyama K; Sato T; Kurokawa MS; Okamoto K; Kimura K; Shibagaki Y; Kato T
    Biochem Biophys Res Commun; 2015 Nov; 467(1):63-9. PubMed ID: 26410531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells.
    Bae EA; Seo H; Kim BS; Choi J; Jeon I; Shin KS; Koh CH; Song B; Kim IK; Min BS; Han YD; Shin SJ; Kang CY
    Cancer Res; 2018 Sep; 78(18):5315-5326. PubMed ID: 30012672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse PVRIG Has CD8
    Murter B; Pan X; Ophir E; Alteber Z; Azulay M; Sen R; Levy O; Dassa L; Vaknin I; Fridman-Kfir T; Salomon R; Ravet A; Tam A; Levin D; Vaknin Y; Tatirovsky E; Machlenkin A; Pardoll D; Ganguly S
    Cancer Immunol Res; 2019 Feb; 7(2):244-256. PubMed ID: 30659055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8
    Li J; Lee Y; Li Y; Jiang Y; Lu H; Zang W; Zhao X; Liu L; Chen Y; Tan H; Yang Z; Zhang MQ; Mak TW; Ni L; Dong C
    Immunity; 2018 Apr; 48(4):773-786.e5. PubMed ID: 29625896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
    Dobrzanski MJ; Reome JB; Hollenbaugh JA; Dutton RW
    J Immunol; 2004 Feb; 172(3):1380-90. PubMed ID: 14734713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Layilin, a novel integral membrane protein, is a hyaluronan receptor.
    Bono P; Rubin K; Higgins JM; Hynes RO
    Mol Biol Cell; 2001 Apr; 12(4):891-900. PubMed ID: 11294894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifaceted Role of BTLA in the Control of CD8
    Ritthipichai K; Haymaker CL; Martinez M; Aschenbrenner A; Yi X; Zhang M; Kale C; Vence LM; Roszik J; Hailemichael Y; Overwijk WW; Varadarajan N; Nurieva R; Radvanyi LG; Hwu P; Bernatchez C
    Clin Cancer Res; 2017 Oct; 23(20):6151-6164. PubMed ID: 28754817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.